tiprankstipranks
Xenetic Biosciences (XBIO)
NASDAQ:XBIO
US Market

Xenetic Biosciences (XBIO) Financial Statements

Compare
295 Followers

Xenetic Biosciences Financial Overview

Xenetic Biosciences's market cap is currently $4.02M. The company's EPS TTM is $-2.569; its P/E ratio is ―; Xenetic Biosciences is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 2.50M$ 2.54M$ 1.71M$ 1.16M$ 436.94K
Gross Profit$ 2.50M$ 2.54M$ 1.68M$ 1.13M$ 436.94K
Operating Income$ -4.20M$ -4.52M$ -6.72M$ -5.75M$ 4.55M
EBITDA$ -4.20M$ -4.54M$ -6.72M$ -5.71M$ -4.69M
Net Income$ -3.96M$ -4.13M$ -6.39M$ -5.54M$ -10.89M
Balance Sheet
Cash & Short-Term Investments$ 6.17M$ 8.98M$ 13.10M$ 18.24M$ 11.53M
Total Assets$ 6.90M$ 10.61M$ 14.72M$ 19.82M$ 13.18M
Total Debt$ 0.00$ 0.00$ 0.00$ 27.04K$ 62.52K
Net Debt$ -6.17M$ -8.98M$ -13.10M$ -18.22M$ -11.47M
Total Liabilities$ 894.26K$ 809.59K$ 1.07M$ 1.42M$ 963.97K
Stockholders' Equity$ 6.01M$ 9.80M$ 13.65M$ 18.39M$ 12.22M
Cash Flow
Free Cash Flow$ -2.82M$ -4.11M$ -5.15M$ -4.74M$ -4.27M
Operating Cash Flow$ -2.82M$ -4.11M$ -4.65M$ -4.74M$ -4.27M
Investing Cash Flow$ 0.00$ 0.00$ -500.00K$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 0.00$ 0.00$ 11.45M$ 5.43M
Currency in USD

Xenetic Biosciences Earnings and Revenue History

Xenetic Biosciences Debt to Assets

Xenetic Biosciences Cash Flow

Xenetic Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis